Skip to main content
. 2023 Sep 25;46(2):1755–1773. doi: 10.1007/s11357-023-00938-8

Fig. 5.

Fig. 5

tRNA synthetase inhibitors increase caspase-like activity through Atf4. A Peptide and protein aggregation of wild type and ATF4 KO MEFs. Protein aggregation assessed using PROTEOSTAT ® divided by the total protein in the sample, normalized to wild type. B Promega’s assay schema to measure caspase-like activity of the proteasome. C–I Caspase-like activity increases in response to different tRNA synthetase inhibitors at ATF4-inducing concentrations (*p < 0.05, **p < 0.01, ***p < 0.001; one-way ANOVA)